Clinical trial

Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers…

NCT00290914 · Pharmacology Research Institute, Other · Completed

Key facts

NCT number NCT00290914
Title Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder
Lead sponsor Pharmacology Research Institute, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Major Depressive Disorder
Intervention type Drug
Interventions Vilazodone
First posted Feb 13, 2006
Last update posted May 9, 2012

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies